Literature DB >> 8783724

Cholera among Americans living in Peru.

D N Taylor1, J Rizzo, R Meza, J Perez, D Watts.   

Abstract

Mesh：

Year:  1996        PMID： 8783724     DOI： 10.1093/clinids/22.6.1108

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama.

Authors:  D N Taylor; J L Sanchez; J M Castro; C Lebron; C M Parrado; D E Johnson; C O Tacket; G A Losonsky; S S Wasserman; M M Levine; S J Cryz
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 2.  Prophylaxis for travelers' diarrhea.

Authors:  Emily Singh; David Redfield
Journal:  Curr Gastroenterol Rep       Date:  2009-08

3.  Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

Authors:  C O Tacket; M B Cohen; S S Wasserman; G Losonsky; S Livio; K Kotloff; R Edelman; J B Kaper; S J Cryz; R A Giannella; G Schiff; M M Levine
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine.

Authors:  Karen K Wong; Erin Burdette; Barbara E Mahon; Eric D Mintz; Edward T Ryan; Arthur L Reingold
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-05-12       Impact factor: 17.586

5.  Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022.

Authors:  Jennifer P Collins; Edward T Ryan; Karen K Wong; Matthew F Daley; Adam J Ratner; Grace D Appiah; Pablo J Sanchez; Bruce J Gutelius
Journal:  MMWR Recomm Rep       Date:  2022-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.